相关实验视频

Updated: May 22, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

开发和验证一个风险评分来预测ST升高心肌梗塞患者的30天死亡率

Shan Wang^1,2,3, You Zhang^4,5,6, Datun Qi^1,3

¹Department of Cardiology, Heart Center of Henan Provincial People's Hospital, Central China Fuwai Hospital, Central China Fuwai Hospital of Zhengzhou University, No. 1 Fuwai Road, Zhengdong New District, Zhengzhou, 451464, Henan, China.

Scientific reports

|March 15, 2025

概括

一个新的两阶段评分系统准确预测ST升高心肌梗塞 (STEMI) 患者的30天死亡率. 这种动态工具平衡了及时性和准确性,优于现有的风险评分,以改善患者管理.

科学领域:

心脏病学心脏病学
临床风险预测预测
医疗信息学医疗信息学

背景情况:

对于ST升高心肌梗塞 (STEMI) 的现有风险评分缺乏及时性,可行性和准确性的平衡.
对STEMI患者30天死亡风险的动态评估对于及时干预至关重要.

研究的目的:

开发和验证一种新的两阶段评分系统,用于对STEMI患者进行动态30天死亡风险评估.
提高现有的风险分层工具的预测能力.

主要方法:

总共有3939名STEMI患者被招募,随机分配到衍生 (N=2757) 和内部验证 (N=1182) 数据集.
一个由1315名STEMI患者组成的独立队列被用于外部验证.
使用多变量分析开发了一个两阶段的评分系统,结合了在第一次医疗接触 (FMC) 和住院期间可用的预测因素.

主要成果:

第一次医疗接触 (FMC) 阶段的风险评分包括年龄,性别,缩血压,心率,基利普等级和前心肌梗塞 (AUC:0.816-0.854).
住院阶段风险得分增加了血清肌素和左心室喷射分数,显示出更好的预测能力 (AUC:0.843-0.876).
新的评分系统在内部和外部验证队伍中,与TIMI和GRACE分数相比,显示出更高的性能和可重复性.

结论:

开发的两阶段评分系统有效预测STEMI患者的30天死亡率.
这种动态工具提供了更高的准确性和可行性,可以更好地识别高风险患者,以便及时管理.

关键词:

30天死亡率30天死亡率动态预测动态预测 ST升高心肌梗塞的心脏病发作两个阶段的评分系统.

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...